Cargando…

Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app

BACKGROUND: Multiple Sclerosis (MS) is a chronic and progressive neurological autoimmune disease currently affecting 250,000 individuals in Germany. Patients suffering from the disease can be severely impaired in their day-to-day activities. BRISA is a digital app specifically designed to help MS pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mountford, Steffeni, Kahn, Maria, Balakrishnan, Preetha, Jacyshyn-Owen, Elizabeth, Eberl, Markus, Friedrich, Benjamin, Joschko, Natalie, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196529/
https://www.ncbi.nlm.nih.gov/pubmed/37214657
http://dx.doi.org/10.1177/20552076231173520
_version_ 1785044375740350464
author Mountford, Steffeni
Kahn, Maria
Balakrishnan, Preetha
Jacyshyn-Owen, Elizabeth
Eberl, Markus
Friedrich, Benjamin
Joschko, Natalie
Ziemssen, Tjalf
author_facet Mountford, Steffeni
Kahn, Maria
Balakrishnan, Preetha
Jacyshyn-Owen, Elizabeth
Eberl, Markus
Friedrich, Benjamin
Joschko, Natalie
Ziemssen, Tjalf
author_sort Mountford, Steffeni
collection PubMed
description BACKGROUND: Multiple Sclerosis (MS) is a chronic and progressive neurological autoimmune disease currently affecting 250,000 individuals in Germany. Patients suffering from the disease can be severely impaired in their day-to-day activities. BRISA is a digital app specifically designed to help MS patients monitor their disease by regularly tracking symptoms. Lengthy and time-consuming questionnaires for patient-reported outcomes (PRO) are the standard method to assess the patients’ current condition. Here, we examine whether simplified versions of these questionnaires can provide comparable information regarding individual symptom presentations in BRISA users. METHODS: 828 users were included in the analysis. Patients who provided onboarding information and answered at least one questionnaire and the corresponding simplified smiley symptoms assessment were included. Correlation of questionnaire and symptom scores was calculated using Pearson's correlation. RESULTS: Our analysis cohort predominantly consisted of female, 26–55-year-olds. Relapsing-remitting MS (RRMS) was the most common MS type recorded. Most patients were diagnosed 2–5 years ago. Questionnaires regarding fatigue and vision impairment were among the most answered, those regarding bowel movement and sexual satisfaction received fewest responses. Overall, the scores from questionnaires and symptoms correlated positively. Scoring correlation could also be shown across the subgroups divided by gender, age groups, type of MS, and time since diagnosis of the disease. CONCLUSION: Scores recorded from traditional PRO questionnaires can be reflected more easily as a trend in a simplified scale using smileys. Nevertheless, traditional questionnaires are needed to also maintain a more objective assessment. In conclusion, the patient will benefit most from an adaptive combination of regular traditional PRO questionnaire assessments and simplified symptom recording.
format Online
Article
Text
id pubmed-10196529
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101965292023-05-20 Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app Mountford, Steffeni Kahn, Maria Balakrishnan, Preetha Jacyshyn-Owen, Elizabeth Eberl, Markus Friedrich, Benjamin Joschko, Natalie Ziemssen, Tjalf Digit Health Original Research BACKGROUND: Multiple Sclerosis (MS) is a chronic and progressive neurological autoimmune disease currently affecting 250,000 individuals in Germany. Patients suffering from the disease can be severely impaired in their day-to-day activities. BRISA is a digital app specifically designed to help MS patients monitor their disease by regularly tracking symptoms. Lengthy and time-consuming questionnaires for patient-reported outcomes (PRO) are the standard method to assess the patients’ current condition. Here, we examine whether simplified versions of these questionnaires can provide comparable information regarding individual symptom presentations in BRISA users. METHODS: 828 users were included in the analysis. Patients who provided onboarding information and answered at least one questionnaire and the corresponding simplified smiley symptoms assessment were included. Correlation of questionnaire and symptom scores was calculated using Pearson's correlation. RESULTS: Our analysis cohort predominantly consisted of female, 26–55-year-olds. Relapsing-remitting MS (RRMS) was the most common MS type recorded. Most patients were diagnosed 2–5 years ago. Questionnaires regarding fatigue and vision impairment were among the most answered, those regarding bowel movement and sexual satisfaction received fewest responses. Overall, the scores from questionnaires and symptoms correlated positively. Scoring correlation could also be shown across the subgroups divided by gender, age groups, type of MS, and time since diagnosis of the disease. CONCLUSION: Scores recorded from traditional PRO questionnaires can be reflected more easily as a trend in a simplified scale using smileys. Nevertheless, traditional questionnaires are needed to also maintain a more objective assessment. In conclusion, the patient will benefit most from an adaptive combination of regular traditional PRO questionnaire assessments and simplified symptom recording. SAGE Publications 2023-05-17 /pmc/articles/PMC10196529/ /pubmed/37214657 http://dx.doi.org/10.1177/20552076231173520 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Mountford, Steffeni
Kahn, Maria
Balakrishnan, Preetha
Jacyshyn-Owen, Elizabeth
Eberl, Markus
Friedrich, Benjamin
Joschko, Natalie
Ziemssen, Tjalf
Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title_full Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title_fullStr Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title_full_unstemmed Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title_short Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
title_sort correlation and differences of patient-reported outcomes vs. likert-rating of ms symptoms in a real-world cohort using a digital patient app
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196529/
https://www.ncbi.nlm.nih.gov/pubmed/37214657
http://dx.doi.org/10.1177/20552076231173520
work_keys_str_mv AT mountfordsteffeni correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT kahnmaria correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT balakrishnanpreetha correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT jacyshynowenelizabeth correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT eberlmarkus correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT friedrichbenjamin correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT joschkonatalie correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp
AT ziemssentjalf correlationanddifferencesofpatientreportedoutcomesvslikertratingofmssymptomsinarealworldcohortusingadigitalpatientapp